Trim 40-45% of EMR NOW at ~$150.21; preserve residual for Q3 FY26 catalyst
Trim 40-45% of EMR exposure immediately at ~$150.21 as a single tranche, rather than waiting for a relief rally to $155-158 that may not materialize. Hard reduction trigger at $146.20 (1 ATR + lower Bollinger band) on volume >2.5M; regime-exit stop at $141.63 (200 SMA). Preserve 55-60% residual for Q3 FY26 print optionality. Re-engagement requires close >$156.69 with MACD positive and volume confirmation, or looser starter signal at $153-155 reclaim with RSI >45 and MACD histogram contracting. The bearish case is supported by $7.24 forward EPS requiring ~65% expansion from $4.40 annualized run-rate at 20.8x forward multiple, while the structural floor (4.4% FCF yield, 1.9x net debt/EBITDA, 69-year dividend streak) prevents full liquidation.
| Position | Action |
|---|---|
| Position weight <2% | No action |
| Position weight 2-4% | Trim 25-30% |
| Position weight 4-6% | Trim 35-40% |
| Position weight >6% | Trim 45-50% |
EMR is a high-quality automation compounder at a reasonable normalized valuation, with improving margins, cash flow, software mix, and a measurable cross-sell opportunity; near-term technical weakness argues for staged accumulation rather than abandoning the investment thesis.
| Indicator | Value | Signal |
|---|---|---|
| Close | 150.21 | bearish |
| 10 EMA | 153.06 | bearish |
| 50 SMA | 148.93 | neutral |
| 200 SMA | 141.63 | bullish |
| RSI (14) | 44.51 | neutral |
| MACD Line | -0.02 | bearish |
| MACD Signal | 1.68 | bearish |
| MACD Histogram | -1.70 | bearish |
| Bollinger Middle (20 SMA) | 157.11 | bearish |
| Bollinger Upper | 166.63 | bearish |
| Bollinger Lower | 147.59 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$156.69 with MACD positive and volume confirmation
Then: Full re-entry signal
↩ rebuts: “Bear: 'EMR is cyclical and exposed to China, tariffs, and process-industry capital spending.'”
EV: ~$159–$181 on forward EPS of $7.24 at normalized 22x–25x multiple (24–36 month horizon) · concedes: Bear wins the tactical momentum argument; MACD remains negative, RSI is not oversold, EMR is below 10-day EMA and VWMA; EMR is not a high-yield income stock (1.4%–1.5% yield); Bear is correct that 33.4x trailing P/E leaves little room for earnings miss; forward P/E of 21.1x already prices in meaningful normalization; Bear is correct that goodwill and intangibles (~66% of assets) and negative tangible book value represent real risks if AspenTech underperforms; Bear is correct that EMR is not a deep-value opportunity; the bull case depends on execution; Bear is correct that interest rates higher-for-longer can cap P/E expansion; Sentiment score of 6.0/10 is mildly bullish and should not be treated as independent confirmation
EMR faces a momentum breakdown with no oversold signal fired, the bull's $7.24 forward EPS is a heroic forecast ~25% above quarterly run-rate annualized, the balance sheet has materially weakened with negative tangible book value and $27.65B in intangibles exposed to write-down risk, and the risk/reward is poor at current prices with 13% downside shown even in the bull's own sensitivity table.
· concedes: EMR's brand portfolio (Fisher, Rosemount, Micro Motion, NI, AspenTech) is genuinely mission-critical, the installed base creates switching costs, and the gross margin of ~53% is impressive for an industrial; The bull correctly acknowledges the chart is bearish, admits valuation is 'not cheap,' and concedes the dividend yield is 'modest' — these concessions strengthen rather than weaken the bear case; The bull's characterization of the balance sheet as 'not a solvency crisis today' is accurate; The strong-jobs/no-cuts combination is not the same as a recession — the 6% recession probability from prediction markets is genuinely low
→ vs conservative: The 40% net income growth is off a depressed base; the $7.24 forward EPS requires 65% expansion, which is a heroic assumption not a normalized base effect
→ vs conservative: The dividend streak and quality compounder argument does not compensate for broken technicals and 1.48% yield cannot bail out a multiple compression event
→ vs conservative: Patience is not a virtue here — it is the most expensive view because you pay in opportunity cost on both sides of the move
→ vs conservative: The 69-year dividend streak argument is valid as a long-term thesis, which is why 60-70% of the position is kept, but it is not a reason to add at $150 with broken technicals
→ vs neutral: Waiting for confirmation (RSI above 50, close above 10 EMA at $153) means reacting AFTER the $3-5 per share drawdown has already occurred
→ vs neutral: Waiting for capitulation flush below $147 with RSI under 35 before adding costs 5% on the position that should have been trimmed
→ vs neutral: The 'balanced' view is actually the most expensive view because you pay opportunity cost on both sides — no downside protection and no efficient mean reversion capture
→ vs conservative: The 'wait through catalysts' approach is dangerous because priced-in catalysts only resolve asymmetrically to the downside; hawkish Powell could compress industrial multiples 5-10%
| neutral |
| ATR (14) | 4.01 | neutral |
| VWMA | 155.18 | bearish |
| Peak Close (8/14) | 163.17 | bearish |
| Cycle Low (9/01) | 146.97 | neutral |
Support: 148.93 · 147.59 · 146.97 · 141.63 | Resistance: 153.06 · 157.11 · 158 · 163 · 163.17 · 164.31 · 166.63
EMR is in a short-term downtrend within a long-term uptrend. Price has broken below the 10 EMA (153.06), 50 SMA (148.93), and VWMA (155.18), with the MACD bearish crossover confirmed and histogram at -1.70. RSI at 44.51 is neutral-bearish and not oversold, while ATR is declining at 4.01 (indicating the panic phase may be passing). The lower Bollinger band at 147.59 held on 9/01 (intra-day low 146.97), and the 200 SMA at 141.63 is the critical long-term support level. Tactical bias is NEUTRAL with short-term downside skew; long-term bias is BULLISH above 141.63.
Market Cap
$85.24 B
Enterprise Value
~$100.8 B
P/E (TTM)
33.4×
Forward P/E
21.1×
PEG Ratio
1.73
P/B
4.18×
EPS (TTM)
$4.57
Forward EPS
$7.24
Dividend Yield
1.48%
Beta
1.23
Revenue (TTM)
$18.64 B
Gross Profit (TTM)
$9.91 B
EBITDA (TTM)
$6.06 B
Net Income (TTM)
$2.58 B
Operating Margin
26.9%
Free Cash Flow (TTM)
$3.71 B
Book Value
$36.54
ROE
12.8%
ROA
6.9%
Debt/Equity
67.7%
Current Ratio
0.90
Total Assets
$41.96 B
Total Debt
$13.76 B
Net Debt
$11.57 B
Equity
$20.28 B
Goodwill + Intangibles
$27.65 B
Free Cash Flow (FY2025)
$2.67 B
Capex (FY2025)
$0.43 B
Operating Cash Flow (FY2025)
$3.10 B
Dividend Paid (FY2025)
$1.19 B
Share Repurchases (FY2025)
$1.17 B
Total Shareholder Yield
~7.9%
Revenue CAGR (4-year)
~7.0%
EBITDA CAGR (4-year)
~8.4%
Net Debt/EBITDA
~1.9×
Interest Coverage (EBIT/Interest)
~8.6×
FCF/Net Income
~144%
Pension Benefit Obligation
$1.27 B
Aspen Technology Acquisition
~$8.3 B
Climate Technologies Sale
~$13.2 B
52-Week High
$166.35
52-Week Low
$122.64
Strengths
Concerns
Emerson Electric has successfully transformed from a diversified industrial conglomerate into a focused automation software and instrumentation company, posting revenue of $18.64B TTM with 7% revenue CAGR over four years and expanding EBITDA margins from ~25% to ~32.5%. The company generates strong free cash flow ($3.71B TTM, ~144% conversion) and maintains a 65+ year dividend Aristocrat streak, though the stock trades near 52-week highs with a trailing P/E of 33.4× (forward P/E of 21.1× more representative) and carries $11.57B net debt post the $8.3B Aspen Technology acquisition, warranting a HOLD rating as new-money buyers should wait for pullbacks while existing holders can remain invested given the ~7.9% total shareholder yield and intact long-term thesis.
Macro: Strong U.S. labor market with 'blowout' August 2026 jobs report supporting a soft-landing/no-landing backdrop; Fed effectively priced out of easing with 93% probability of zero rate cuts in 2026; recession odds at historically low 6%; gold holding near $4,500/oz; most-likely September 2026 unemployment at 4.1–4.2% (~26% each). Higher-for-longer rate regime is base case — positive for capital-goods/industrial automation end markets but keeps financial conditions tighter than 2020–21.